Nottingham, United Kingdom

John Francis Unitt

USPTO Granted Patents = 4 


Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2020-2022

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: John Francis Unitt: Innovator in Medical Treatments

Introduction

John Francis Unitt is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of medicine, particularly in the development of treatments for various diseases. With a total of four patents to his name, Unitt's work has the potential to impact many lives.

Latest Patents

Among his latest patents are "ADO-resistant cysteamine analogs and uses thereof," which focuses on methods for treating diseases for which cysteamine is indicated. This patent includes compounds that are useful in such methods. Another significant patent is related to "Methods for treating Cushing's syndrome," which provides methods for assessing a clinical response to a glucocorticoid receptor antagonist (GRA) in human subjects and for diagnosing Cushing's syndrome.

Career Highlights

Throughout his career, Unitt has worked with various companies, including Corcept Therapeutics Incorporated and Horizon Orphan LLC. His innovative approaches have contributed to advancements in medical treatments and therapies.

Collaborations

Unitt has collaborated with notable individuals in the field, including Joseph K Belanoff and Hazel Joan Hunt. These partnerships have likely enhanced the scope and impact of his work.

Conclusion

John Francis Unitt's contributions to medical innovation through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to pave the way for new treatments and therapies that can improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…